Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2008-2231
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia ; volume:29 ; number:2 ; day:21 ; month:9 ; year:2021 ; pages:507-510 ; date:12.2021
DARU ; 29, Heft 2 (21.9.2021), 507-510, 12.2021
- Urheber
-
Budzianowski, Jan
Rzeźniczak, Janusz
Hiczkiewicz, Jarosław
Kasprzak, Dominika
Winnicka-Zielińska, Anna
Musielak, Bogdan
Pieszko, Konrad
Burchardt, Paweł
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40199-021-00417-5
- URN
-
urn:nbn:de:101:1-2022012819213320862195
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Budzianowski, Jan
- Rzeźniczak, Janusz
- Hiczkiewicz, Jarosław
- Kasprzak, Dominika
- Winnicka-Zielińska, Anna
- Musielak, Bogdan
- Pieszko, Konrad
- Burchardt, Paweł
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anemia in Patients with Severe Aortic Stenosis
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment
Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
Empagliflozin reduces interleukin-6 levels in patients with heart failure
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia
Anemia in severe heart failure patients: does it predict prognosis?
Anti-inflammatory potential of Empagliflozin
Empagliflozin: a potential anticancer drug
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Anemia in Patients with Severe Aortic Stenosis
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment
Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
Empagliflozin reduces interleukin-6 levels in patients with heart failure
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia
Anemia in severe heart failure patients: does it predict prognosis?
Anti-inflammatory potential of Empagliflozin
Empagliflozin: a potential anticancer drug
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia
Anemia in Patients with Severe Aortic Stenosis
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment
Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats
Empagliflozin reduces interleukin-6 levels in patients with heart failure
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia
Anemia in severe heart failure patients: does it predict prognosis?
Anti-inflammatory potential of Empagliflozin
Empagliflozin: a potential anticancer drug
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice